Welcome to GTx, a biopharmaceutical company dedicated to the discovery, development, and
commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Our recognized scientific expertise is in the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. Click to learn more about our products in development.
GTx is a biopharmaceutical company dedicated to the discovery, development and commercialization of drug candidates. Click to learn more about the GTx management team.
GTx Provides Corporate Update and Reports Third Quarter 2013 Financial Results 
GTx, Inc. To Host Third Quarter 2013 Financial Results Conference Call and Webcast
GTx Presents Results from Enobosarm POWER Trials for the Prevention and Treatment of Muscle Wasting in Patients with Non-Small Cell Lung Cancer at 15th World Conference on Lung Cancer